{"ticker": {"uuid": "6c02db42-433d-4918-8688-945b0edead32", "symbol": "HIK", "name": "Hikma Pharmaceuticals PLC", "exchange": "LSE", "country": "GB", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "What's Behind Hikma Pharmaceuticals' (LSE:HIK) New UK Office Push To Support NHS Supply?", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOenhNcDZ0ZC1Ba0QtOWs2dHFpdU1KRVFicUlsbjl5b1lvVU1VRm5Ua1F2MmdBdlJhNTh2SGlCWWZEeEZZQ1g2NHVkLUdPek9hRWo4aWV0b0V4LXB6WXhlUlRfcDZtdWl3VG4xUUc0eGNOVGVLSXMzV3ZNZ3poLXNLd2phYktOcURudnB6UGpMSGNuQmtrb1BpcHIzSUxrZWhsTGdZS2N3Qy1DUGlmS3dQbkJWR2dhc1h0ay1XZFUtMkwtQ3dWZFJr?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-16T06:48:00+00:00", "published_display": "16 Jul 2026 06:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Cancels More Shares as $250m Buyback Passes 10 Million Mark", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNRjMxMlpINnpHY19PT0lrb3JPbi1IMUgxX3hPUGFzaXFWRG9ReFIzSGlDN3NONUt4M0VJMGZKaDhGMXF1cC1FS2hFVzVnMHp6cVZIMWk5MVBucVdyazRXSnA5UXN4RUIyel9vR3QwbHprWUxHWFhycURsellYRUQwX2YzdUtCaXhLWElMOTY4R0VyU09SeDN3eHNaa1JXNE9YcFhka0xseTAyXzBIaVE2bE5wX1pBdXZvcE03ZW9SVTBHX1lIM1dVZDBnandEVGxIOVA2ZE8xZURCcWExTWc?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-14T09:55:36+00:00", "published_display": "14 Jul 2026 09:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Could Hikma Pharmaceuticals (LSE:HIK) Be The Generics Story London Is Watching?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNNTEwbnZoS0F3SUR2WFNhYXo5UDJCT1I2RlEzamtmMmY5VEJqbEFnZUkzZ1AxU3ZpNXBKSURSd3FPc09sRVZzQndEVHdUeEV0aDNPMGZQRXR4OFM3SGJheDVjM08wUFdsMF9TN2NhN0NFTzNMNmN5VFNzMm5zNm1hLUZ6MU9LdnZtYUlhQjBTMlBPVmJXOFIyWmNFcVFyRjNfOHpYTjNTR2NBMVQ0d3BEOF8xenpqNUNYTUZtQXdn?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-13T09:00:00+00:00", "published_display": "13 Jul 2026 09:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC highlights its generics and injectables strength", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQeHAyNmxXQ2NVLUlqNWdlSWNMdHJISzdCMkVpbXl2TS1oWldkTHpqZEpqc3d4OUtLTDlWV3JHNlVTTDU1S3ljcmdiYVFKYWl5RXZfWHRpV2FKc2YzaG5yWnZSb3NWVnJyWm0yc1FtUjVzX3diOHA0WVVXWjBQSUVubGpma09mWTRoMjMwMjVpaWtRTWh1S2h6WVBOZi13QlVLS25kSGU5U3lpQnBNMW5Yd0JkZDVIN3RzRzdhQ0wtRGdrLUJRbGUzbXBsdGR0UQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-08T07:48:56+00:00", "published_display": "08 Jul 2026 07:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC outlines growth ambitions as a global generics supplier", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOYUphcnhwb185THFjWHdLRkszQ0xrQTlKd01CdERTRFBYbTZ5ZHVURFRGWU14QnZmb25heWsyLVZzYVI0Y1R1VnUzVm5DS0ZaazVFNDg4VjdUaXdjSFFxYWg1NDhsRHpfZnRyRGMyV0pMcUlWREU1UHRudE02b2wyT1drUWVTSC1BRWlycjQ3cDV1S1JCc19NQ3BiSmZMMVAycnFVLXcwMlNndEkzVUJTLVpXRlRHSERSR3U3Yi11NDA1RnlQZzdlbldDMA?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-07T06:29:53+00:00", "published_display": "07 Jul 2026 06:29", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Hikma Pharmaceuticals Plc \u2013 LSE:HIK", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxObGs5bVd5Qk0zTlJoN1pENmJsU0xUOXlOZVFwa2xnOW0xOHpsaExJUWhvZXJNcTRpSmgyaHNaZ2pIeWJCekMydmtPODVxeklHVmNsQU15YjBzMkhudm1UTTZQbDN6cXY5V0p0Qk81dFpnSzQteFVzM3BVZEk5ZXFOMEdTUGJrZjEtX25HOW5yTk1CSUtXekVDVlVYR0ZTeTlWaFdQVTc3dXU?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T21:35:42+00:00", "published_display": "26 Jun 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Are AstraZeneca, GSK and Hikma Lifting FTSE 100 Focus?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNamM3aUJaNFlpcXYxYWFjT0NoSFg5NXRfOVRTa0swMXoyeWlNQXd0VkNuekZyaVpKTlRseTlfQTJrMGhGUDFvQi1QX3NtN2RnTVM2ckRKUndXSjJVOU1nRFJ6a3Q1YU82RkpmODdKZzR4V25HWlE2aHNPX1lWeHJLVGFXRkxQUTRjZGJiazV0eDlReld4STFkcmVtQzUzT3Vib3c?oc=5", "source_name": "Kalkine Media", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): earnings momentum and US injectables footprint in fo", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPVkg5Z3BUMTRNTDJMSjVFN2NlYS12cVBnVFk2QnVLaWZocXNtRFMtcFU3djFnOTJsVGhBSlM2a0RnajBFZUZ4NV8yUU85SGM4Nk5FWm1NRVF2aWM3cEtOdGlxTDNqcnZXRy15dWNFUHdKN0I5RmRweVBnOG1ZX2N1eGREMHBwd1I1N1ptM3pxYlpwRGpnZ3RWU3hXd21aam5WU1U5Q0dQYVZ2SGlTelpZaEFacEU0dTFuWkpueXdmQ2pzLVlVM1ow?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Hikma Pharmaceuticals (LSE:HIK) Narrative Is Shifting After Analyst Valuation Resets", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQQnFibmxJWWV3cEtfWVM2V2hGdjZlaDh5MlRxckRURVEtampVUGJXeWtuem5fWFJnXzQ0YVdlWHh4Qm5BbE93NTFzcXVzZUZMV09JM0RmRmhTRi04TUFqNUpzVUlxYnI5cmZUXzliNzM4QW1xNGFOVV9zTkFJamlabDd6b0p6VGo3MHM4dVAtUVNkeXUtT3lUOE5URmV3aHU3a0s0bHBDVQ?oc=5", "source_name": "Market source", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Independent Chairman of Hikma Pharmaceuticals Victoria Hull Buys 241% More Shares", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Investment Story On Hikma Pharmaceuticals (LSE:HIK) Is Shifting With New Targets And News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxObmdVdFMyeTFaaUdxZ1lvYndwcjZTaVRXZ1ZwaG4yV0dRenRud2NOTDFoUHlmMzByaVRzd0pJa1gtSHU1LW5RY3FBN2YxeTVHdDVOdDBhQW84N0cwbFYtZFZhMl9Fbldpc25wQjFOZjRRTHlmTnZEOGlJZlNFSUJ6MDBjTHU2TXpObExFSkJBdmQ0WDItZmxxa3dHUFBfN1kxczQ2TjM3RlhTWjQ?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Hikma Pharmaceuticals (LSE:HIK) Narrative Is Shifting As Analyst Targets Reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOR290NkVOdGprcl9mU19DM2JSR2xPbVVVV20wNElzOThDaUw5SG1LeXFkRkNvbmlOVVpqaFRPZHAxQm1EaGwzQmx1ZGFYeldNdWduRG5aTEU2RGNqNFE2dDZKSzVrbzkyM0RPMkdqS1RRQnZIREliaWNoLVhveUJ6cHRRRGpyWnlQenUxZFYzR1RHell3QXY3RVVYbDU4VjB1OEFDM050cw?oc=5", "source_name": "Market source", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharma tumbles on softer guidance as buyback fails to soften pill", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQYThWZFFUeFhvZU5tdFcwaUpNNU9sckVDeFB1UnR3c0tMUG9OdkZlR3dCLWpOeW50WHZWUm1KRjhJY0pzT01ZSEpXX1lYRTc0RklxZkhCeXNTdVQzMmNhZW0zVzdZV2g5ekJFbnFJamc4dWE4UG1ENkpoTFZueDlwV2FyMXpMQkJJbHEyZ2F3?oc=5", "source_name": "Market source", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharma's gloomy outlook kicks shares to more than three-year low", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPeVFrb0JZRUJHN29WTTRVYjF3bTQyQ0pIMmZZZjdRdXdFa1NaaXY0VWlfaC1hQzR0TE1HdUtrMHNuZDNqZVZnYm1TMW5nemVWV0hoc1h5Q3ZPNHlXcDRBV3h3ZUQxSDZrUG84ckE3YU1vMGlqQnlWRDNaV1UtU19qWmkySVdOem1EZFpOZnZvTmxaNGRqbnI2dmhEVG9BMThXSjVmYy04c1pFRGRaWTgwSG5kUHdWXzMxZ2VrRlJudEVnTy1mZGlaUDRSM3dlVWY0VEE?oc=5", "source_name": "Reuters", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma\u2019s shares plummet after guidance cut", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOMXVlWlhsQS1tLU5PY21qaHBTTm9HZWJlNUNSZG1DLS1rT1hQWGxqVUowSVNmZmlieFhWdFNnSE1fcWQ3R0l6b3FSeG5ndGdwT2tfQkJhanJLRmQ4ZlFYUTZCczdDWk9xQmtEWXBZOGNvR3BKSnJIcGIzNks0XzUwNEJnMU5rUDhU?oc=5", "source_name": "Investors' Chronicle", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC (LON:HIK) is largely controlled by institutional shareholders who own 59% of the company", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC (HIK.L) Stock Analysis: Unraveling a 41.93% Potential Upside with Strong Buy Ratings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxONjlrdWZjenI1X3hncFVQbXdSbHlpNDBYX2lTLXM2RkdncjIxOUpfbXlsRldkZGYzaUE4c3ZBOVA2eDNaOGhiTWtIX0Q1Y2ktZEdyWVFZU21kUGJtckg3bjlmQm92U3dabVM2TXVoNl9jQ3RYVkE1b1Y4a2N2M1BOQlVvMFB2SzBmZkh6eHFpU2ptSlRrdkl4cUxPdGRrMFNhc3o0VklsTTd1OGloN3I5a0ZONEZ6MmFFZFIxVFFENVIzeHVBMnRhQXJFZnZjNW1rYmNBY1BNVmFwSU5RaVRDZE53SkpER0pQTTV3SUZn?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC (LON:HIK) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxQTng2RmctbmVhZW5IY3hCcFlBVExMa3RvQVJDcy1PZmxUTVR5S1dWMjJNbUR0OG1zcDd4VFphZDNqWDJrNW10RXZkSjhINDhFaE5jdWV6RmJRSVU2SVhhNnVWU3Jzd0UyRmR1d2hCb3E5cXZFNlBGUFVBWEZkMVhtMlZKY2tyZzZHSXo1eS1HUnU5cE42RXZFc3JLT1JUeUdMWEM4VDBSakpuY01fYWJndmhlNzlJUWItbksyeWlWd0F1N1lMakktcHYwYzNhbTNkejBxMXJNa0pNT0tQUXZzd2pBVFB6MHF3VDEzS19ta9IB9AFBVV95cUxPcW11UWp2dmRZQm1pb1EwV053dlFybDRWakJHWDl4c1NHaTN5OGM1Z3VkbzFyOE5aUWdZQWJ0aEpBS0ZnYUFVV1p5dThzRFh4bU84YTRwOFp1b1BjV0hnMHZMa050aFc0UUlzNUcyMDN4NHp3WlkyLThaMEVzTlYxbkFUUGRlLUpUUXQtcmVyZWZaSWxuVUZta3M4Y2t3WDRjYnJVb3NuQmNxYmNES1NiRWhvQXV6QjE0dnA3U1JwWVVFNXB2THo3SnNuUXp2MUNkbkpBcnJtLXVMdlFFRkVDQUE3VzZzdUl5OFl0Q2p2WU9lVkcw?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-10T08:00:00+00:00", "published_display": "10 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors in Hikma Pharmaceuticals (LON:HIK) have unfortunately lost 33% over the last five years", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-19T08:00:00+00:00", "published_display": "19 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UK's Hikma CEO steps down, chairman takes helm until successor appointed", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNLUZLWk1FcUNDZTlOOExJVmd1SEJyTlB1YlB4WUR1TGJGaXBpX19PbzV4NUcwcVFaOUQ3UjlQZTlyVWtFYllzcTRsVElKWjdZYURlTkZUak40UVhaaE5lVmRjbTlWQTZ1TzJHUXUxSTM0RVBESG14R3ZWMDdLbkdfTlhkekJwZjVsdVVOekVnVjlPRVJBeHlSMm8zR2cxbXRJYnN1NnBYaG96SzJSdGl4ZnBEa2Q?oc=5", "source_name": "Reuters", "published_at": "2025-12-14T08:00:00+00:00", "published_display": "14 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Market Cool On Hikma Pharmaceuticals PLC's (LON:HIK) Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-01T08:00:00+00:00", "published_display": "01 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC (HIK) Stock Price Quote Today & Current Price Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQc3hXZmoyS0pFd1VSNkFjNDFWVDV5RV9Tbmk1WlJ2MDRsY3ZHVVZ0ZTQtUXNTWGNqRUdKeFNxdFpZam9LRE84cWdiY3ZEQzdYTldOaWlJZ09peVVRVHVpYVc1Q0x0bThpaFcwWm5mc2J1ZnNRcWlzeHdjUGVDamowRXVmZ1FhTHZG?oc=5", "source_name": "Capital.com", "published_at": "2025-11-12T18:14:28+00:00", "published_display": "12 Nov 2025 18:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Do Hikma Pharmaceuticals' (LON:HIK) Earnings Warrant Your Attention?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-10T07:00:00+00:00", "published_display": "10 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals: a quality compounder waiting for a catalyst", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNd3h6ejF2QXZTajFFX3FEaDJaZWhQQ3NWNDFVQnFRVGhRRVZ0dDFieFpITnNoRldlNjNtV1p2c1hGMXlaQ2E4b2J5ZGdMblV4NTFSTW5ISFNYRWFUZDVIYnlIVXUwbTBUQVhnMkdwSTVDYTRIekhOVW93cm5DOE85cnJxX1dvUmF4ekRCb01BMkxLWjY3ellob0txZWE2ZlJfRXY5QXZUNlZMaVVZ?oc=5", "source_name": "The Armchair Trader", "published_at": "2025-07-24T07:00:00+00:00", "published_display": "24 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "What's Behind Hikma Pharmaceuticals' (LSE:HIK) New UK Office Push To Support NHS Supply?", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOenhNcDZ0ZC1Ba0QtOWs2dHFpdU1KRVFicUlsbjl5b1lvVU1VRm5Ua1F2MmdBdlJhNTh2SGlCWWZEeEZZQ1g2NHVkLUdPek9hRWo4aWV0b0V4LXB6WXhlUlRfcDZtdWl3VG4xUUc0eGNOVGVLSXMzV3ZNZ3poLXNLd2phYktOcURudnB6UGpMSGNuQmtrb1BpcHIzSUxrZWhsTGdZS2N3Qy1DUGlmS3dQbkJWR2dhc1h0ay1XZFUtMkwtQ3dWZFJr?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-16T06:48:00+00:00", "published_display": "16 Jul 2026 06:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Cancels More Shares as $250m Buyback Passes 10 Million Mark", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxNRjMxMlpINnpHY19PT0lrb3JPbi1IMUgxX3hPUGFzaXFWRG9ReFIzSGlDN3NONUt4M0VJMGZKaDhGMXF1cC1FS2hFVzVnMHp6cVZIMWk5MVBucVdyazRXSnA5UXN4RUIyel9vR3QwbHprWUxHWFhycURsellYRUQwX2YzdUtCaXhLWElMOTY4R0VyU09SeDN3eHNaa1JXNE9YcFhka0xseTAyXzBIaVE2bE5wX1pBdXZvcE03ZW9SVTBHX1lIM1dVZDBnandEVGxIOVA2ZE8xZURCcWExTWc?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-14T09:55:36+00:00", "published_display": "14 Jul 2026 09:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Could Hikma Pharmaceuticals (LSE:HIK) Be The Generics Story London Is Watching?", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNNTEwbnZoS0F3SUR2WFNhYXo5UDJCT1I2RlEzamtmMmY5VEJqbEFnZUkzZ1AxU3ZpNXBKSURSd3FPc09sRVZzQndEVHdUeEV0aDNPMGZQRXR4OFM3SGJheDVjM08wUFdsMF9TN2NhN0NFTzNMNmN5VFNzMm5zNm1hLUZ6MU9LdnZtYUlhQjBTMlBPVmJXOFIyWmNFcVFyRjNfOHpYTjNTR2NBMVQ0d3BEOF8xenpqNUNYTUZtQXdn?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-13T09:00:00+00:00", "published_display": "13 Jul 2026 09:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC highlights its generics and injectables strength", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQeHAyNmxXQ2NVLUlqNWdlSWNMdHJISzdCMkVpbXl2TS1oWldkTHpqZEpqc3d4OUtLTDlWV3JHNlVTTDU1S3ljcmdiYVFKYWl5RXZfWHRpV2FKc2YzaG5yWnZSb3NWVnJyWm0yc1FtUjVzX3diOHA0WVVXWjBQSUVubGpma09mWTRoMjMwMjVpaWtRTWh1S2h6WVBOZi13QlVLS25kSGU5U3lpQnBNMW5Yd0JkZDVIN3RzRzdhQ0wtRGdrLUJRbGUzbXBsdGR0UQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-08T07:48:56+00:00", "published_display": "08 Jul 2026 07:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC outlines growth ambitions as a global generics supplier", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOYUphcnhwb185THFjWHdLRkszQ0xrQTlKd01CdERTRFBYbTZ5ZHVURFRGWU14QnZmb25heWsyLVZzYVI0Y1R1VnUzVm5DS0ZaazVFNDg4VjdUaXdjSFFxYWg1NDhsRHpfZnRyRGMyV0pMcUlWREU1UHRudE02b2wyT1drUWVTSC1BRWlycjQ3cDV1S1JCc19NQ3BiSmZMMVAycnFVLXcwMlNndEkzVUJTLVpXRlRHSERSR3U3Yi11NDA1RnlQZzdlbldDMA?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-07T06:29:53+00:00", "published_display": "07 Jul 2026 06:29", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Hikma Pharmaceuticals Plc \u2013 LSE:HIK", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxObGs5bVd5Qk0zTlJoN1pENmJsU0xUOXlOZVFwa2xnOW0xOHpsaExJUWhvZXJNcTRpSmgyaHNaZ2pIeWJCekMydmtPODVxeklHVmNsQU15YjBzMkhudm1UTTZQbDN6cXY5V0p0Qk81dFpnSzQteFVzM3BVZEk5ZXFOMEdTUGJrZjEtX25HOW5yTk1CSUtXekVDVlVYR0ZTeTlWaFdQVTc3dXU?oc=5", "source_name": "TradingView", "published_at": "2026-06-26T21:35:42+00:00", "published_display": "26 Jun 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Are AstraZeneca, GSK and Hikma Lifting FTSE 100 Focus?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNamM3aUJaNFlpcXYxYWFjT0NoSFg5NXRfOVRTa0swMXoyeWlNQXd0VkNuekZyaVpKTlRseTlfQTJrMGhGUDFvQi1QX3NtN2RnTVM2ckRKUndXSjJVOU1nRFJ6a3Q1YU82RkpmODdKZzR4V25HWlE2aHNPX1lWeHJLVGFXRkxQUTRjZGJiazV0eDlReld4STFkcmVtQzUzT3Vib3c?oc=5", "source_name": "Kalkine Media", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): earnings momentum and US injectables footprint in fo", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPVkg5Z3BUMTRNTDJMSjVFN2NlYS12cVBnVFk2QnVLaWZocXNtRFMtcFU3djFnOTJsVGhBSlM2a0RnajBFZUZ4NV8yUU85SGM4Nk5FWm1NRVF2aWM3cEtOdGlxTDNqcnZXRy15dWNFUHdKN0I5RmRweVBnOG1ZX2N1eGREMHBwd1I1N1ptM3pxYlpwRGpnZ3RWU3hXd21aam5WU1U5Q0dQYVZ2SGlTelpZaEFacEU0dTFuWkpueXdmQ2pzLVlVM1ow?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Hikma Pharmaceuticals (LSE:HIK) Narrative Is Shifting After Analyst Valuation Resets", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQQnFibmxJWWV3cEtfWVM2V2hGdjZlaDh5MlRxckRURVEtampVUGJXeWtuem5fWFJnXzQ0YVdlWHh4Qm5BbE93NTFzcXVzZUZMV09JM0RmRmhTRi04TUFqNUpzVUlxYnI5cmZUXzliNzM4QW1xNGFOVV9zTkFJamlabDd6b0p6VGo3MHM4dVAtUVNkeXUtT3lUOE5URmV3aHU3a0s0bHBDVQ?oc=5", "source_name": "Market source", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Independent Chairman of Hikma Pharmaceuticals Victoria Hull Buys 241% More Shares", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Investment Story On Hikma Pharmaceuticals (LSE:HIK) Is Shifting With New Targets And News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxObmdVdFMyeTFaaUdxZ1lvYndwcjZTaVRXZ1ZwaG4yV0dRenRud2NOTDFoUHlmMzByaVRzd0pJa1gtSHU1LW5RY3FBN2YxeTVHdDVOdDBhQW84N0cwbFYtZFZhMl9Fbldpc25wQjFOZjRRTHlmTnZEOGlJZlNFSUJ6MDBjTHU2TXpObExFSkJBdmQ0WDItZmxxa3dHUFBfN1kxczQ2TjM3RlhTWjQ?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Hikma Pharmaceuticals (LSE:HIK) Narrative Is Shifting As Analyst Targets Reset", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxOR290NkVOdGprcl9mU19DM2JSR2xPbVVVV20wNElzOThDaUw5SG1LeXFkRkNvbmlOVVpqaFRPZHAxQm1EaGwzQmx1ZGFYeldNdWduRG5aTEU2RGNqNFE2dDZKSzVrbzkyM0RPMkdqS1RRQnZIREliaWNoLVhveUJ6cHRRRGpyWnlQenUxZFYzR1RHell3QXY3RVVYbDU4VjB1OEFDM050cw?oc=5", "source_name": "Market source", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharma tumbles on softer guidance as buyback fails to soften pill", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQYThWZFFUeFhvZU5tdFcwaUpNNU9sckVDeFB1UnR3c0tMUG9OdkZlR3dCLWpOeW50WHZWUm1KRjhJY0pzT01ZSEpXX1lYRTc0RklxZkhCeXNTdVQzMmNhZW0zVzdZV2g5ekJFbnFJamc4dWE4UG1ENkpoTFZueDlwV2FyMXpMQkJJbHEyZ2F3?oc=5", "source_name": "Market source", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharma's gloomy outlook kicks shares to more than three-year low", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPeVFrb0JZRUJHN29WTTRVYjF3bTQyQ0pIMmZZZjdRdXdFa1NaaXY0VWlfaC1hQzR0TE1HdUtrMHNuZDNqZVZnYm1TMW5nemVWV0hoc1h5Q3ZPNHlXcDRBV3h3ZUQxSDZrUG84ckE3YU1vMGlqQnlWRDNaV1UtU19qWmkySVdOem1EZFpOZnZvTmxaNGRqbnI2dmhEVG9BMThXSjVmYy04c1pFRGRaWTgwSG5kUHdWXzMxZ2VrRlJudEVnTy1mZGlaUDRSM3dlVWY0VEE?oc=5", "source_name": "Reuters", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma\u2019s shares plummet after guidance cut", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxOMXVlWlhsQS1tLU5PY21qaHBTTm9HZWJlNUNSZG1DLS1rT1hQWGxqVUowSVNmZmlieFhWdFNnSE1fcWQ3R0l6b3FSeG5ndGdwT2tfQkJhanJLRmQ4ZlFYUTZCczdDWk9xQmtEWXBZOGNvR3BKSnJIcGIzNks0XzUwNEJnMU5rUDhU?oc=5", "source_name": "Investors' Chronicle", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC (LON:HIK) is largely controlled by institutional shareholders who own 59% of the company", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC (HIK.L) Stock Analysis: Unraveling a 41.93% Potential Upside with Strong Buy Ratings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxONjlrdWZjenI1X3hncFVQbXdSbHlpNDBYX2lTLXM2RkdncjIxOUpfbXlsRldkZGYzaUE4c3ZBOVA2eDNaOGhiTWtIX0Q1Y2ktZEdyWVFZU21kUGJtckg3bjlmQm92U3dabVM2TXVoNl9jQ3RYVkE1b1Y4a2N2M1BOQlVvMFB2SzBmZkh6eHFpU2ptSlRrdkl4cUxPdGRrMFNhc3o0VklsTTd1OGloN3I5a0ZONEZ6MmFFZFIxVFFENVIzeHVBMnRhQXJFZnZjNW1rYmNBY1BNVmFwSU5RaVRDZE53SkpER0pQTTV3SUZn?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC (LON:HIK) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-10T08:00:00+00:00", "published_display": "10 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors in Hikma Pharmaceuticals (LON:HIK) have unfortunately lost 33% over the last five years", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7wFBVV95cUxPSlFnbi1jUkFFMm00dzJuN1hSaGZYQV8tMmtLUTk2aTV2Zk5nN1BlMzNJOTl1S25WbG1fR0I3Y0RrbEFrVEluUUxycWRRQmItWFdMOG9xMkZnZkV5R1VGWGxydFo4dDZmYjVvX1lWSEtVWUJ6UUM5M1JtLXpBSVZ0VFpnTGpWVE1Ba2J1M2VIOHpLUU1nc2dTcUxpVkpuZkNDY3A4NTRXUnBRX2pEcXE2T1RVUWo4eTVONDY0VVFhQjg4R1ZwUHM1d3RmV29zMXBZZW12WjlRbUpKRVZvM1dSRkI0cDJFODY5R0pfVDExVdIB9AFBVV95cUxPNlh0TExVa08xOERIUUFGd3FWMUF5aGo5TmVPWlBaa20zbC1wZjQxSHNwVVVabHNPeUVJS1VZYVhZWENtNUxEMmFzbFAxbWIyWk1BckNuX3g4el9JZTloY1lISXRmcXItNk9MNlhXVTd5MzlNQk1lZGZBNGFORTRmV1V5Y2VBSjVvQlZnUXdFZjBrejVhQ01BZVQyRDZvWGVXTWVlWmlTTGwzQ2RYTERoV19oaVRNV0x3ejA3QXBidEY2VzFQVTlHYzlsbkU4d24zMkhUTVZ3NktFSEFoZmhFbTlpb1FjVkkwdzVzX3ZlYzRVLWJ1?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-19T08:00:00+00:00", "published_display": "19 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UK's Hikma CEO steps down, chairman takes helm until successor appointed", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNLUZLWk1FcUNDZTlOOExJVmd1SEJyTlB1YlB4WUR1TGJGaXBpX19PbzV4NUcwcVFaOUQ3UjlQZTlyVWtFYllzcTRsVElKWjdZYURlTkZUak40UVhaaE5lVmRjbTlWQTZ1TzJHUXUxSTM0RVBESG14R3ZWMDdLbkdfTlhkekJwZjVsdVVOekVnVjlPRVJBeHlSMm8zR2cxbXRJYnN1NnBYaG96SzJSdGl4ZnBEa2Q?oc=5", "source_name": "Reuters", "published_at": "2025-12-14T08:00:00+00:00", "published_display": "14 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Market Cool On Hikma Pharmaceuticals PLC's (LON:HIK) Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-01T08:00:00+00:00", "published_display": "01 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC (HIK) Stock Price Quote Today & Current Price Chart", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQc3hXZmoyS0pFd1VSNkFjNDFWVDV5RV9Tbmk1WlJ2MDRsY3ZHVVZ0ZTQtUXNTWGNqRUdKeFNxdFpZam9LRE84cWdiY3ZEQzdYTldOaWlJZ09peVVRVHVpYVc1Q0x0bThpaFcwWm5mc2J1ZnNRcWlzeHdjUGVDamowRXVmZ1FhTHZG?oc=5", "source_name": "Capital.com", "published_at": "2025-11-12T18:14:28+00:00", "published_display": "12 Nov 2025 18:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Do Hikma Pharmaceuticals' (LON:HIK) Earnings Warrant Your Attention?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-10T07:00:00+00:00", "published_display": "10 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals: a quality compounder waiting for a catalyst", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNd3h6ejF2QXZTajFFX3FEaDJaZWhQQ3NWNDFVQnFRVGhRRVZ0dDFieFpITnNoRldlNjNtV1p2c1hGMXlaQ2E4b2J5ZGdMblV4NTFSTW5ISFNYRWFUZDVIYnlIVXUwbTBUQVhnMkdwSTVDYTRIekhOVW93cm5DOE85cnJxX1dvUmF4ekRCb01BMkxLWjY3ellob0txZWE2ZlJfRXY5QXZUNlZMaVVZ?oc=5", "source_name": "The Armchair Trader", "published_at": "2025-07-24T07:00:00+00:00", "published_display": "24 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 70, "total_relevant": 25, "sentiment_summary": {"positive": 2, "negative": 1, "neutral": 22, "score": 52, "total": 25, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 8.05, "count": 14}, {"event": "guidance", "label": "Guidance", "weight": 2.0, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}, {"event": "capital_return", "label": "Capital return", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 1584.0, "latest_week": "2026-07-10", "one_week_move": 2.3, "four_week_move": 7.0, "twelve_week_move": 14.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.213792, "market_dynamics_buy_signal": false, "relative_strength": -6.399953, "fair_value_gap": -13.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 52.3434, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.3% over one week, +7.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "simplywall.st", "count": 6}, {"label": "ad-hoc-news.de", "count": 4}, {"label": "Market source", "count": 4}, {"label": "Kalkine Media", "count": 3}, {"label": "Reuters", "count": 2}, {"label": "The Globe and Mail", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "Investors' Chronicle", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 25}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 14}, {"label": "Earnings", "count": 3}, {"label": "Guidance", "count": 3}, {"label": "Capital return", "count": 2}, {"label": "Analyst action", "count": 2}, {"label": "Macro sensitivity", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "25", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.3% over one week, +7.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "What's Behind Hikma Pharmaceuticals' (LSE:HIK) New UK Office Push To Support NHS Supply?"}], "updated_at": "2026-07-17T04:25:02.061246+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}